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0022-2836 © 2011 Elsevier Ltd. Open accThe p53 family of transcription factors—comprising p53, p63 and p73—
plays an important role in tumor prevention and development. Essential to
their function is the formation of tetramers, allowing cooperative binding to
their DNA response elements. We solved crystal structures of the human
p63 tetramerization domain, showing that p63 forms a dimer of dimers with
D2 symmetry composed of highly intertwined monomers. The primary
dimers are formed via an intramolecular β-sheet and hydrophobic helix
packing (H1), a hallmark of all p53 family members. Like p73, but unlike
p53, p63 requires a second helix (H2) to stabilize the architecture of the
tetramer. In order to investigate the impact of structural differences on
tetramer stability, we measured the subunit exchange reaction of p53 family
homotetramers by nanoflow electrospray mass spectrometry. There were
differences in both the kinetics and the pattern of the exchange reaction,
with the p53 and p63 tetramers exhibiting much faster exchange kinetics
than p73. The structural similarity between p63 and p73 rationalizes
previous observations that p63 and p73 form mixed tetramers, and the
kinetic data reveal the dissociation of the p73 homotetramers as the rate-
limiting step for heterotetramer formation. Differential stability of the
tetramers may play an important role in the cross talk between different
isoforms and regulation of p53, p63 and p73 function in the cell cycle.© 2011 Elsevier Ltd. Open access under CC BY license.Introduction
The transcription factors p53, p63 and p73 play an
important role in cancer prevention, development
and longevity.1–4 The three proteins share a similar
domain organization (Fig. 1a), being composed of
structured DNA-binding domain (DBD) and tetra-
merization domain flanked by intrinsically disor-
dered regions. 2,7,8 The phylogenetically more
ancient p63 and p73 proteins have an extended
C-terminal region that is absent in p53. This regionress:
inding domain;
ization mass
nk; SeMet,
-square deviation;
vation domain.
ess under CC BY license.contains a structured sterile α-motif (SAM)
domain9–11 and, in the case of p63, an additional
inhibitory domain at the extreme C terminus that
negatively regulates the transcriptional function of
p63.12 The proteins are active as tetramers, allowing
cooperative binding of four DBDs to target promot-
er sites. 13 Tetramers are formed via a short
tetramerization domain that follows the DBD,
with a short flexible linker region separating the
two domains. Solution and crystal structures of the
tetramerization domain have been solved for p53
and p73,14–19 but not for p63. Both p53 and p73
form dimers of dimers with D2 symmetry. The p73
tetramerization domain contains an additional C-
terminal helix that is important for stabilizing the
tetramer.17,18 The three family members can interact
with each other, although two fundamentally
different molecular mechanisms for interaction
have to be distinguished: formation of mixed
tetramers and co-aggregation. The oligomerization
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Fig. 1. Structural organization of human p53, p63 and p73. (a) Schematic comparison of the domain structure of full-
length p53, p63 and p73, showing the N-terminal TAD, proline-rich region (PR), DBD, tetramerization domain (TET),
SAM domain (p63 and p73) and transactivation inhibitory domain (TI). See the text for further details. (b) Alignment of
p53 family tetramerization domain sequences. The C-terminal amino acids shown for each family member correspond to
the 3′-end of exon 10 encoding the tetramerization domain.5 Residues conserved in all three family members are
highlighted in green, whereas residues conserved in only two members are highlighted in light blue. Secondary-structure
elements in the crystal structure of p63(359–402) are indicated by black letters: e (β-strand), h (α-helix) and g (310-
helix). Orange letters show the results from consensus secondary-structure prediction for the residues not resolved in the
crystal structure using the NPS@ protein sequence analysis Web server.6 p63 residues forming interdimer contacts are
marked with red circles, whereas black circles denote residues involved in intradimer contacts. Residues with black open
circles contribute to this interface primarily via their main-chain atoms.
504 Structure of the p63 Tetramerization Domaindomains of p63 and p73 can form mixed tetramers,
suggesting functional cross talk, whereas p53 does
not form heterotetramers with its family
members.17,18,20 Some p53 cancer mutants possess
oncogenic gain of function via interaction with p63
and p73 despite the tetramerization domains not
interacting with each other. A recent study has
shown that this effect is caused by an aggregation-
prone sequence within the hydrophobic core of the
DBD, which is conserved in the p53 family.21 This
region is exposed in conformationally unstable p53
cancer mutants, triggering co-aggregation with
wild-type p53, as well as p63 and p73. A large
number of isoforms of p53, p63 and p73 can be
expressed as a result of alternative splicing of C-
terminal exons or the use of two alternative
promoters.5 For p63 and p73, the latter results in
isoforms with either an intact transactivation do-
main (TAD), essential for the transactivation of
target genes (TAp63 and TAp73), or dominant-
negative isoforms lacking the TAD (ΔNp63 and
ΔNp73). Interplay between the different isoforms
via formation of mixed tetramers is thought to be an
important mechanism in controlling the overall
function of p53 family members.8 A recent study
has shown that p63 function in mouse oocytes is
regulated via the oligomerization state of p63.22 Inits latent state, p63 forms dimers with reduced
transcriptional activity through an intramolecular
inhibition of tetramer formation involving the N and
C termini interacting with the tetramerization
domain.
Here, we report crystal structures of different p63
tetramerization domain variants, showing not only
marked similarity to p73 but also small differences
that may be important for regulating the function of
p63 in vivo. In addition, we measured the kinetics of
subunit exchange for different p53 family members
using nanoflow electrospray ionization mass spec-
trometry (nESI-MS). These data show that the p73
tetramer is kinetically the most stable of the three
p53 family members, which has potential implica-
tions for the functional cross talk of different
isoforms and formation of p63/p73 heterotetramers.Results
Structure of the human p63 tetramerization
domain
Initial crystallization trials with a human p63
tetramerization domain variant comprising residues
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Fig. 2. Stereo view of the p63 tetramerization domain structure. (a) Structure of the p63(359–402) tetramer shown as
cartoon representation. Individual subunits are shown in different colors. Selected side chains at the tetramer interface are
shown as stick models and labeled. (b) Superposition of the tetramerization domains of p63, p73 (PDB code 2WQI)17 and
p53 (PDB code 1C26).14 The tetramers are superimposed based on one of the two primary dimers, for example, the yellow
and green chains in (a).
505Structure of the p63 Tetramerization Domain356–411, p63(356–411), resulted only in poorly
diffracting crystals. We then systematically truncated
the C-terminal region, which significantly improved
the crystal quality, and we were able to solve the
structure of p63(359–402). This tetramerization
domain variant comprises the equivalent of the
C-terminal residues forming key interactions in the
crystal structure of the p73 homolog.17 In addition,
we also solved the structure of a variant lacking the
C-terminal helix altogether, that is, containing only
the structural elements of the canonical p53 tetra-
merization domain motif (Fig. 1b). Both structures
were solved using selenomethionine (SeMet)-
substituted proteins and multiwavelength anoma-
lous dispersion phasing. The crystal structure of the
long variant was solved at a resolution of 2.15 Å. The
crystals belonged to space group P422 and con-
tained one monomer in the asymmetric unit. Like its
family members, p63 forms dimers of dimers with
D2 symmetry (Fig. 2). The overall structure of the
p63 tetramerization domain is very similar to that of
p73 (2WQI; an RMSD of 1.5 Å over the aligned Cαatoms with 55% sequence identity). The monomers
consist of a β-strand followed by two helices, H1
and H2, the latter being absent in the p53 homolog.
They adopt a z-shaped double-hairpin conformation
with virtually no intramolecular contacts between
the different structural elements. Two such mono-
mers dimerize via intermolecular antiparallel
β-sheet and antiparallel packing of the H1 helices
(e.g., the green and yellow chains in Fig. 2a).
Important hydrophobic contacts are made by
Leu364, Val366, Tyr372, Met374, Leu375, Ile378
and Leu382. The total surface area buried within
this dimer is 2120 A2.
Tetramers are formed via largely hydrophobic
H1–H1 interactions of two primary dimers and H2-
mediated contacts (Fig. 3). The H2 helices from one
primary dimer reach across and clasp the adjacent
primary dimer, with the two primary dimers
packing in approximately orthogonal fashion via
their H1 helices (Figs. 2 and 3a). Key interacting
residues are conserved in p63 and p73, but there are
some notable variations, resulting in differences in
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Fig. 3. p63 dimer–dimer interface. (a) Molecular surface of the p63 tetramer (left). The view is perpendicular to the
β-sheets, showing the C-terminal helices with Tyr396 clasping the neighboring dimer. The two primary dimers are shown
in gray and green, respectively. Removal of the green dimer reveals the contact area of the central hydrophobic dimer–
dimer interface (right). Selected contact residues in the H1–H1 interface (Met374 and Ile378) and the H2 helix (Tyr396 and
Arg397) are labeled. Atom color code: oxygen, red; nitrogen, blue; carbon, gray; sulfur, yellow. (b) Stereo view of the
H1/H2 linker region and H2-mediated interactions with the adjacent primary dimer. Polar interactions are highlighted
with magenta broken lines.
506 Structure of the p63 Tetramerization Domainsurface complementarity. At the center of the
tetrameric p63 interface, for example, the Ile378
side chains from each subunit contact each other,
whereas the corresponding residues in p53 and p73
are leucines (Leu344 and Leu371, respectively).
Helix H2, which is essential for the stability of the
tetramer, forms both hydrophobic and polar inter-
subunit contacts: the latter comprise a hydrogen
bond between Tyr396 and Glu383′ and a salt bridge
between Arg397 and Glu380′ (Fig. 3b). In addition to
formation of an intermolecular hydrogen bond,
Tyr396 stabilizes the tetramer interface through
hydrophobic interactions with Leu384′ and
Tyr387′. Tyr396, Arg397 and the interacting gluta-
mates on the H1 helix are conserved in p63 and p73.
Residues in the sharp H1/H2 turn and the
N-terminal region of H2 are less conserved (see Fig. 1),but the resulting interface with the adjacent subunit
is similar in nature and characterized by hydropho-
bic interactions. Interestingly, the first turn of helix
H2 differs in the two orthologs. p63 has a histidine
(His391) instead of the proline found in p73,
indicating a lower structural rigidity of this region
in p63.
The last four residues of the construct used for
crystallization, Gln399 to Gln402, were not resolved
in the crystal structure, indicating a high degree of
flexibility. A comparable conformational flexibility
of C-terminal H2 residues was also observed in one
of the two crystal forms reported for the p73
tetramerization domain [Protein Data Bank (PDB)
code 2WTT]. Based on secondary-structure predic-
tion, helix H2 potentially extends up to residue 409
(see Fig. 1) and would thus significantly protrude
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Fig. 4. p63 tetramerization domain structure upon deletion of the second helix. (a) Overall structure of the tetramer
observed in the asymmetric unit of the crystal structure of p63(359–388). Contrary to the orthogonal packing of primary
dimers in the full-length protein, the tetramer is formed via antiparallel packing of H1 helices from adjacent dimers. (b)
Superposition of the primary dimers in the structures of p63(359–402) with H2 helix (green) and p63(359–388) lacking this
helix (light brown).
507Structure of the p63 Tetramerization Domainbeyond the compact core of the tetramer. This region
is significantly longer in p63 than in p73 because of a
five-residue insertion within the glutamine-rich
C-terminal region. The high conformational flexibil-
ity of the C-terminal region of H2 would explain the
failure to obtain crystals that diffracted well for the
longer p63 tetramerization domain constructs.
Structure of the p63 tetramerization domain
upon deletion of the H2 helix
Deletion of the H2 helix has been shown to
substantially destabilize the p63 and p73 tetramers,
and much higher protein concentrations were
needed to shift the equilibrium toward tetrameric
species.17,18 We solved the crystal structure of such a
truncated variant of p63, p63(359–388), at a resolu-
tion of 1.9 Å. Interestingly, this crystal structure,
solved in the space group P1, contained one
tetramer in the asymmetric unit but with funda-
mentally different packing characteristics than those
observed for the longer variant (Fig. 4). The primary
dimers are formed as observed for the longer
variant, that is, by formation of an intermolecular
β-sheet and antiparallel packing of the H1 helices.These primary dimers, however, pack in an anti-
parallel fashion to form tetramers, which is in stark
contrast to the orthogonal packing observed in the
full-length tetramers of p53, p63 and p73. In
addition, there are small differences in the structure
of the primary dimers, most notably, a difference in
packing angle and conformation of the H1 helix.
This helix adopts an α-helical conformation
throughout, whereas the packing interactions in
the full-length variant cause a distortion at the
C-terminal end of the helix and a transition to a 310-
helical conformation (see Fig. 4b). Key hydrophobic
interactions at the center of the primary dimer
interface are conserved. Similar shifts in H1 packing
angles and conformation have been observed for
p73 upon truncation of the C-terminal helix.17 In the
case of the p73 crystal structure, both tetramers and
hexamers were found in the asymmetric unit. As
observed for the p63 structure, these higher-order
oligomers are formed by antiparallel packing of
primary dimer building blocks, in contrast to the
approximately orthogonal packing of the primary
dimers in the full-length tetramers. Hence, loss of
the second helix in p63 and p73 not only weakens
the tetramer but also fundamentally alters the
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Fig. 5. Kinetics of subunit exchange of p53 family tetramerization domains. The exchange of p63 (a), p73 (b) and p53 (c)
tetramerization domains at 37 °C was monitored by nESI-MS after mixing 12C–14N-labeled variants (L; black open circles)
and 13C–15N-labeled variants (H; black filled circles) of each family member. Selected mass spectrometry spectra at
different time points are shown (left). The relative intensities of the species were calculated from the spectra and plotted
against time (right), showing differences in exchange kinetics and patterns when comparing the different familymembers.
We plotted the averages of the two homotetramers and the two 3:1 complexes (L3H1/L1H3).
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Table 1. Kinetic stability of p53 family tetramers at 37 °C
Tetramer Half-life, t1/2 (min)
a
p53(325–356) 5±0.5
p63(356–411) 7±1
p73(351–399) 77±5
a Determined by mass spectrometry monitoring the subunit
exchange of isotopically labeled and unlabeled oligomerization
domain variants.
509Structure of the p63 Tetramerization Domainoverall orientation of the H1 helix packing, revealing
a high degree of fluidity of this interface in the
absence of the H2 helix.
Kinetic stability of the p63 tetramerization
domain compared to p53 and p73
We measured the kinetic stability of p53, p63 and
p73 tetramerization domains by nESI-MS. Equal
amounts of unlabeled protein (12C–14N=“L”) and
uniformly labeled protein (13C–15N=“H”) were
mixed, and the distribution of the various tetrameric
species at different time points after mixing was
monitored by nESI-MS. The measurements were
performed at 37 °C using the full-length tetramer-
ization domain variants p63(356–411) and p73(351–
399) that had previously been used to measure the
formation of mixed tetramers.17 The initial concen-
tration of the homotetramers was in the low
micromolar range so that the starting species were
mainly tetrameric, given that the monomer–dimer
and dimer–tetramer equilibrium constants for the
different p53 family members are in the nanomolar
range.13,23 Immediately after mixing, only homo-
tetrameric species were observed, containing either
“light” (L4) or “heavy” subunits (H4). In the case of
p63, significant populations of mixed species with
L2H2, L3H1 and L1H3 stoichiometries were already
observed after 10 min of incubation. After about
50 min, equilibrium was reached. The ratio of L4,
L3H1, L2H2, L1H3 and H4 was 1:4:6:4:1, as expected
for a statistical distribution (Fig. 5a). Kinetic model-
ing showed that the tetramers dissociate with a half-
life, t1/2, of about 7 min (Table 1). For the p73
tetramerization domain, the subunit exchange pro-
ceeded much more slowly (Fig. 5b). The p73
tetramers had a 10× longer half-life than the p63
tetramers, and equilibrium was only reached after
about 10 h. As with p63, the ratio at equilibriumwas
consistent with a statistical distribution of subunits.
The p53 tetramer had the shortest half-life of the
three family members, with a t1/2 of about 5 min
(Table 1). There was a notable qualitative difference
in the subunit exchange process for p53 (Fig. 5c). The
2:2 complexes reached equilibrium almost instantly,
whereas the 3:1 complexes were formed much more
slowly, in contrast to p63 and p73, for which the
complexes reached equilibrium at a comparablerate. These data indicate that intradimer and
interdimer interfaces are of a comparable strength
in p63 and p73, respectively, but differ significantly
in p53 where the dimer interface is muchmore stable
than the tetramer interface. The kinetic stabilities of
the isolated tetramerization domains measured by
nESI-MS parallel the differential dissociation con-
stants of full-length p53, ΔNp63β and ΔNp73β
determined by analytical ultracentrifugation,13
showing that the p73 tetramer is the most stable of
the three orthologs.Discussion
We have solved the crystal structure of the p63
tetramerization domain, thereby completing the
picture of the structural evolution of this domain
within the human p53 family. The overall structure
of the p63 tetramerization domain is very similar to
that of the p73 domain but distinct from that of p53
in that it contains an additional helix while retaining
the overall symmetry and basic architecture of the
tetramer. A common feature of the three family
members is the formation of dimers of dimers with
D2 symmetry and approximately orthogonal pack-
ing of the dimers. The structural data are consistent
with earlier biophysical studies on this domain,
showing that the additional C-terminal helix, H2, is
essential for stabilizing the tetramer.17,18 The H2
helices from one primary dimer reach across the
adjacent dimer, thus stabilizing the tetramer. The
fact that this helix is found only in the more ancestral
and phylogenetically more closely related members,
p63 and p73, reflects an evolutionary pathway
toward smaller building blocks in p53 that do not
interact with their more ancestral family members.17
The overall architecture of the p63 and p73
tetramers suggests a zip-like dissociation mecha-
nism by which H2-mediated interactions have to be
broken first before the tetramer can dissociate into
dimers and monomers. Despite their similar archi-
tecture, there are subtle structural differences
affecting the stability of the tetramers that may
play an important role in the regulation of p63 and
p73 transcriptional activities in vivo. Our mass
spectrometry data on the kinetics of subunit
exchange of the different p53 family members
show that the p63 tetramer has a significantly
lower kinetic stability than the p73 homolog, and
accordingly, the p63 tetramers dissociate more
rapidly. It will be interesting to see whether this is
due to specific variations within the central hydro-
phobic tetramer interface or the result of a higher
intrinsic flexibility of the H2 helix in p63. While the
central polar interaction network via the H2 helix is
conserved, there are several amino acid variations in
the hinge region between helices H1 and H2 and the
N-terminal half of H2 (Fig. 1b). One of the two
510 Structure of the p63 Tetramerization Domainprolines at the N-terminal end of the H2 helix in p73
(Pro384), for example, is replaced by a histidine in
p63 (His391), which may affect the conformational
flexibility of this helix. Interestingly, a recent study
has shown that the activity of TAp63α in mouse
oocytes is regulated via its oligomerization state.22
In the latent state, the N and C termini of p63
interact with the oligomerization domain, stabiliz-
ing a dimeric transcriptionally less active form of
p63 and inhibiting tetramer formation. This inhibi-
tion is relieved upon phosphorylation, and active
tetramers are formed. Chemical shift mapping by
NMR suggests that the interaction sites of the H2
helix and the N terminus overlap.22 Hence, in-
creased conformational flexibility of helix H2 may
be necessary for fine-tuning the regulation mecha-
nism of p63 in mouse oocytes. Given the structural
similarity between the p63 and p73 oligomerization
domains, similar activity switches via modulation of
the oligomerization state may also be involved in
regulating p73 function.
We and others have previously shown that p63
and p73 form mixed tetramers, whereas the p53
tetramerization domain does not form heterotetra-
mers with its family members.17,18 On the basis of
the similarity of the p63 and p73 structures and
conservation/homology of key interacting residues,
this observation is now easy to rationalize, as the
subunits can replace each other without perturba-
tion of the overall architecture of the tetramer.
Intriguingly, the 2:2 complex formed by association
of two primary dimers of p63 and p73 is thermody-
namically more stable than the homotetramers.18
Thus, the asymmetric tetramer interface in the
mixed tetramer is more stable than the symmetric
interfaces of the parent tetramers as a result of
improved packing interactions. In vitro data on the
kinetics of heterotetramer formation show that the
subunit exchange occurs on a relatively slow
timescale.17 The data on the kinetic stability of the
homotetramers presented here reveal that dissocia-
tion of the kinetically more stable p73 tetramer is the
rate-limiting step in the formation of mixed tetra-
mers of p63 and p73. The higher kinetic stability of
the p73 tetramer also suggests that p73 tetramers
may be less prone to dominant-negative effects via
formation of mixed tetramers with its isoforms than
p63. However, it is clear that differential kinetic
stability of the tetramers is only one factor in a
complex system in vivo, in addition to differential
expression patterns and differential control of
protein degradation via ubiquitin ligases, a control
mechanism recently shown for TAp73 and
ΔNp73.24 Importantly, recent studies on different
p53 variants have shown that the half-life of p53
tetramers is also modulated by domain–domain
interactions not involving the oligomerization
domain 25 and interactions with accessory
proteins.26 Future studies will show how suchinteractions influence the half-life of full-length p63
and p73 tetramers, as well as their numerous
isoforms. Overall, the structure and stability of p53
family tetramers provide intriguing insights not
only into the structural evolution of this protein
family but also into the evolution of intricate
molecular mechanisms regulating protein function
at various stages of cell development.Methods
Cloning, gene expression and protein purification
p63 and p73 tetramerization domain variants were
produced as described previously.17 Briefly, cDNA clones
of human p63 and p73 were purchased from Geneservice
Ltd. Different regions of the tetramerization domain of p63
and p73were cloned into vector pRSET-HLT using BamHI
andEcoRI restriction sites. The resulting plasmid encodes a
fusion proteinwith anN-terminal 6×His tag, followed by a
lipoyl domain, a thrombin cleavage site and the p63/p73
sequence of interest. The oligomerization domains were
expressed in Escherichia coli strain BL21 and purified using
a Ni-affinity column followed by cleavage with thrombin
(Sigma) overnight. Subsequent purification via a second
Ni-affinity column, anion-exchange chromatography on Q
Sepharose and gel filtration on Superdex 75 yielded a
purity of N99%. The purified samples were concentrated to
10–15 mg/ml, flash frozen and stored in liquid nitrogen.
As a result of the cloning strategy employed, the
recombinant proteins contained a Gly–Ser dipeptide at
their N terminus. To produce SeMet-substituted proteins,
we grew cells in M9 minimal medium supplemented with
50mg/l SeMet and 100mg/l essential amino acids, and the
protein purification bufferswere supplementedwith 7mM
β-mercaptoethanol to prevent oxidation of SeMet. The p53
tetramerization domain (residues 325–356) was produced
in E. coli Bl21 cells as untagged protein using a pRSET
vector, and subsequent purification included anion-ex-
change chromatography on Q Sepharose and gel filtration
on Superdex 75. To produce labeled p53, p63 and p73
variants for subunit exchange experiments by mass
spectrometry, we grew cells in M9 minimal medium
supplemented with minerals and vitamins, together with
1 g/l 15NH4Cl and
13C D-glucose.Crystallography and structure analysis
p63 oligomerization domain crystals were grown at
17 °C using the sitting-drop vapor diffusion technique. We
mixed 1-μl protein solution [12–15 mg/ml protein in
20 mM Tris (pH 8.5) and 50 mM NaCl] and 1-μl
crystallization buffer above a reservoir solution of 100 μl.
Crystals were obtained using the following crystallization
buffers: 30% polyethylene glycol 400, 0.1MHepes (pH 7.5)
and 0.2 M Mg chloride for p63(359–388) and 10%
polyethylene glycol 8000, 0.1 M Hepes (pH 7.5) and
0.2 M Ca acetate for p63(359–402) (both native and SeMet-
substituted crystals). Crystals were either flash frozen
directly in liquid nitrogen [p63(359–388)] or soaked in
mother liquor supplemented with 20% glycerol before
Table 2. X-ray data collection and refinement statistics
Protein p63(359–388) SeMet p63(359–402) SeMet
p63(359–402)
native
Data collection
Space group P1 P422 P422
a, b, c (Å) 30.14, 33.13, 34.68 58.21, 58.21, 39.38 58.20, 58.20, 39.33
α, β, γ (°) 105.33, 102.07, 110.15 90.00, 90.00, 90.00 90.00, 90.00, 90.00
Data set Peak Inflection Remote Peak Inflection Remote Native
Wavelength (Å) 0.9796 0.9797 0.9686 0.9791 0.9793 0.9677 0.9791
Resolution (Å)a 31.6–1.9 31.6–1.9 31.6–1.9 58.2–2.46 58.2–2.46 58.2–2.46 58.2–2.15
(2.0–1.9) (2.0–1.9) (2.0–1.9) (2.60–2.46) (2.60–2.46) (2.60–2.46) (2.27–2.15)
Unique reflections 8661 8662 8701 2700 2701 2708 3966
Completeness (%)a 96.5 (96.6) 96.5 (96.6) 96.3 (96.6) 99.6 (100) 99.7 (100) 99.8 (100) 99.4 (99.8)
Multiplicitya 3.7 (3.8) 3.7 (3.8) 3.7 (3.8) 8.5 (8.4) 8.4 (8.4) 8.5 (8.5) 9.4 (9.7)
Rmerge (%)
a,b 7.5 (9.0) 8.0 (9.1) 7.5 (9.0) 5.8 (23.7) 5.8 (23.7) 5.5 (30.0) 4.7 (80)
〈I/σI〉
a 12.1 (9.0) 12.1 (9.1) 11.5 (8.9) 21.2 (6.9) 21.2 (6.9) 21.1 (6.2) 23.7 (3.3)
Wilson B value (Å2) 20.7 20.9 20.8 66.4 67.8 69.0 52.2
Refinement
Molecules per
asymmetric unit
4 1
Protein/water
atoms
954/50 332/0
Rcryst (%)
c 20.4 23.5
Rfree (%)
c 25.2 28.5
RMSD bonds (Å) 0.013 0.012
RMSD angles (°) 1.5 1.4
Mean B value (Å2) 23.9 81.0
Ramachandran
favored (%)d
100 97.4
Ramachandran
outliers (%)d
0 0
a Values in parentheses are for the highest-resolution shell.
b Rmerge =∑(Ih,i− 〈Ih〉)/∑Ih,i
c Rcryst and Rfree =∑||Fobs|−|Fcalc||/∑|Fobs|, where Rfree was calculated over 5% of the amplitudes chosen at random and not used
in the refinement.
d Determined using MolProbity.35
†http://www.ebi.ac.uk/pdbe/prot_int/pistart.html
‡www.pymol.org
511Structure of the p63 Tetramerization Domainflash freezing [p63(359–402)]. X-ray data sets were
collected on beamlines I02, I03 and I04 at the Diamond
Light Source. All data were indexed and integrated
using MOSFLM27 and further processed with SCALA.28
The structures were solved by multiwavelength anom-
alous dispersion phasing using SeMet-substituted crys-
tals. SeMet sites were found with SHELXD29 using
peak, inflection and remote data sets. For p63(359–388),
the coordinates of these sites were imported into
autoSHARP,30 phases were calculated and an initial
model was built. For p63(359–402), phasing was per-
formed using autoSHARP, and the initial model was built
using Buccaneer.31 Subsequently, the models were refined
using Coot,32 PHENIX33 and REFMAC534 including TLS
refinement (one TLS group per monomer). In the case of
p63(359–402), the model was extended to higher resolu-
tion using the native data set. Data collection and
refinement statistics are summarized in Table 2. The
final model of p63(359–402) comprising residues 359–398
had Rcryst and Rfree values of 23.5% and 28.5%, respec-
tively. The overall B-factor of 81 Å2 reflects mobility and
disorder of the molecules in the crystal, which was partly
modeled through the TLS refinement. The N-terminal
glycine–serine tag and the four C-terminal residues could
not be modeled, which contributed to the relatively high
Rfree value. It is not unexpected for a structure of a small
domain to have a relatively high Rfree value for a givenresolution because a few poorly/unmodeled disordered
residues at the termini result in larger differences between
calculated and measured structure factors than in larger
proteins where they only marginally contribute to the total
scattering. Buried surface areas were calculated using the
PISA server†.36 Structural figures were produced using
PyMOL‡.
Monitoring subunit exchange by mass spectrometry
In a typical subunit exchange reaction, equal amounts
of [12C–14N] and [13C–15N] p53, p63 or p73 in 500 mM
ammonium acetate (pH 6.9) were mixed and incubated at
37 °C. The final concentration of each component in the
three exchange reactions was 10 μM (monomer concen-
tration), that is, the measurements were performed at a
concentration where all species are tetrameric. At
different time points after mixing, samples were taken,
and nESI-MS were recorded on a Synapt HDMS system
(Waters Corporation, Milford, MA) optimized for the
transmission of noncovalent complexes.37 We introduced
1–3 μl of the protein mixture by electrospray from gold-
coated borosilicate capillaries prepared in-house as
512 Structure of the p63 Tetramerization Domaindescribed previously.38 The following experimental pa-
rameters were applied: capillary voltage=1.0–1.3 kV,
sample cone = 100 V, trap and transfer collision
energy=100 V, backing pressure=5 mbar, source pres-
sure=0.06–0.07 mbar, trap pressure=0.05 mbar, ion-
mobility spectrometry pressure=0.5 mbar and time-of-
flight analyzer pressure=1.2×10−6 mbar. Calibration,
data processing, spectra simulation and kinetic modeling
were performed as described previously.39
Accession numbers
The atomic coordinates and structure factor amplitudes
for the p63 tetramerization domain structures have been
deposited in the PDB§ (PDB codes 3ZY0 and 3ZY1).Acknowledgements
We thank Sir Alan Fersht for his continuing
support and Carol Robinson for giving us access to
the mass spectrometry facilities at the Department of
Chemistry of the University of Oxford. We also
thank Sridharan Rajagopalan for protein purifica-
tion and the staff at beamlines I02, I03 and I04 at the
Diamond Light Source for technical assistance
during data collection. Further, we would like to
thank Henning Tidow, Roger Williams, Garib
Murshudov and Caroline Blair for helpful discus-
sions and valuable comments on the manuscript.
This work was supported by the Medical Research
Council Program Grant G0901534.References
1. Vousden, K. H. & Prives, C. (2009). Blinded by the light:
the growing complexity of p53. Cell, 137, 413–431.
2. Dötsch, V., Bernassola, F., Coutandin, D., Candi, E. &
Melino, G. (2010). p63 and p73, the ancestors of p53.
Cold Spring Harbor Perspect. Biol. 2, a004887.
3. Nekulova, M., Holcakova, J., Coates, P. & Vojtesek, B.
(2011). The role of p63 in cancer, stem cells and cancer
stem cells. Cell. Mol. Biol. Lett. 16, 296–327.
4. Melino, G. (2011). p63 is a suppressor of tumorigenesis
and metastasis interacting with mutant p53. Cell Death
Differ. 18, 1487–1499.
5. Murray-Zmijewski, F., Lane, D. P. & Bourdon, J. C.
(2006). p53/p63/p73 isoforms: an orchestra of iso-
forms to harmonise cell differentiation and response
to stress. Cell Death Differ. 13, 962–972.
6. Combet, C., Blanchet, C., Geourjon, C. & Deleage, G.
(2000). NPS@: network protein sequence analysis.
Trends Biochem. Sci. 25, 147–150.
7. Joerger, A. C. & Fersht, A. R. (2008). Structural biology
of the tumor suppressor p53. Annu. Rev. Biochem. 77,
557–582.§www.pdb.org8. Levine, A. J., Tomasini, R., McKeon, F. D., Mak, T. W.
& Melino, G. (2011). The p53 family: guardians of
maternal reproduction. Nat. Rev., Mol. Cell Biol. 12,
259–265.
9. Sathyamurthy, A., Freund, S. M., Johnson, C. M.,
Allen, M. D. & Bycroft, M. (2011). Structural basis of
p63α SAM domain mutants involved in AEC syn-
drome. FEBS J. 278, 2680–2688.
10. Chi, S. W., Ayed, A. & Arrowsmith, C. H. (1999).
Solution structure of a conserved C-terminal domain
of p73 with structural homology to the SAM domain.
EMBO J. 18, 4438–4445.
11. Wang, W. K., Bycroft, M., Foster, N.W., Buckle, A. M.,
Fersht, A. R. & Chen, Y. W. (2001). Structure of the
C-terminal sterile α-motif (SAM) domain of human
p73α. Acta Crystallogr., Sect. D: Biol. Crystallogr. 57,
545–551.
12. Straub, W. E., Weber, T. A., Schäfer, B., Candi, E.,
Durst, F., Ou, H. D. et al. (2010). The C-terminus of p63
contains multiple regulatory elements with different
functions. Cell Death Dis. 1, e5.
13. Brandt, T., Petrovich, M., Joerger, A. C. & Veprintsev,
D. B. (2009). Conservation of DNA-binding specificity
and oligomerisation properties within the p53 family.
BMC Genomics, 10, 628.
14. Jeffrey, P. D., Gorina, S. & Pavletich, N. P. (1995).
Crystal structure of the tetramerization domain of the
p53 tumor suppressor at 1.7 angstroms. Science, 267,
1498–1502.
15. Lee, W., Harvey, T. S., Yin, Y., Yau, P., Litchfield, D. &
Arrowsmith, C. H. (1994). Solution structure of the
tetrameric minimum transforming domain of p53.
Nat. Struct. Biol. 1, 877–890.
16. Clore, G. M., Ernst, J., Clubb, R., Omichinski, J. G.,
Kennedy, W. M., Sakaguchi, K. et al. (1995). Refined
solution structure of the oligomerization domain of
the tumour suppressor p53. Nat. Struct. Biol. 2,
321–333.
17. Joerger, A. C., Rajagopalan, S., Natan, E., Veprintsev,
D. B., Robinson, C. V. & Fersht, A. R. (2009). Structural
evolution of p53, p63, and p73: implication for
heterotetramer formation. Proc. Natl Acad. Sci. USA,
106, 17705–17710.
18. Coutandin, D., Löhr, F., Niesen, F. H., Ikeya, T.,
Weber, T. A., Schäfer, B. et al. (2009). Conformational
stability and activity of p73 require a second helix in
the tetramerization domain. Cell Death Differ. 16,
1582–1589.
19. Mittl, P. R., Chène, P. & Grütter, M. G. (1998).
Crystallization and structure solution of p53 (residues
326–356) by molecular replacement using an NMR
model as template. Acta Crystallogr., Sect. D: Biol.
Crystallogr. 54, 86–89.
20. Davison, T. S., Vagner, C., Kaghad, M., Ayed, A.,
Caput, D. & Arrowsmith, C. H. (1999). p73 and p63
are homotetramers capable of weak heterotypic
interactions with each other but not with p53. J. Biol.
Chem. 274, 18709–18714.
21. Xu, J., Reumers, J., Couceiro, J. R., De Smet, F.,
Gallardo, R., Rudyak, S. et al. (2011). Gain of function
of mutant p53 by coaggregation with multiple tumor
suppressors. Nat. Chem. Biol. 7, 285–295.
22. Deutsch, G. B., Zielonka, E. M., Coutandin, D., Weber,
T. A., Schäfer, B., Hannewald, J. et al. (2011). DNA
513Structure of the p63 Tetramerization Domaindamage in oocytes induces a switch of the quality
control factor TAp63α from dimer to tetramer. Cell,
144, 566–576.
23. Rajagopalan, S., Huang, F. & Fersht, A. R. (2011).
Single-molecule characterization of oligomerization
kinetics and equilibria of the tumor suppressor p53.
Nucleic Acids Res. 39, 2294–2303.
24. Sayan, B. S., Yang, A. L., Conforti, F., Tucci, P., Piro,
M. C., Browne, G. J. et al. (2010). Differential control of
TAp73 and ΔNp73 protein stability by the ring finger
ubiquitin ligase PIR2. Proc. Natl Acad. Sci. USA, 107,
12877–12882.
25. Natan, E., Baloglu, C., Pagel, K., Freund, S. M.,
Morgner, N., Robinson, C. V. et al. (2011). Interaction
of the p53 DNA-binding domain with its N-terminal
extension modulates the stability of the p53 tetramer.
J. Mol. Biol. 409, 358–368.
26. Rajagopalan, S., Jaulent, A. M., Wells, M., Veprintsev,
D. B. & Fersht, A. R. (2008). 14-3-3 activation of DNA
binding of p53 by enhancing its association into
tetramers. Nucleic Acids Res. 36, 5983–5991.
27. Leslie, A. G. (1999). Integration of macromolecular
diffraction data. Acta Crystallogr., Sect. D: Biol. Crystal-
logr. 55, 1696–1702.
28. Evans, P. (2006). Scaling and assessment of data quality.
Acta Crystallogr., Sect. D: Biol. Crystallogr. 62, 72–82.
29. Sheldrick, G. M. (2008). A short history of SHELX.
Acta Crystallogr., Sect. A: Found. Crystallogr. 64,
112–122.
30. Vonrhein, C., Blanc, E., Roversi, P. & Bricogne, G.
(2007). Automated structure solution with auto-
SHARP. Methods Mol. Biol. 364, 215–230.
31. Cowtan, K. (2006). The Buccaneer software for auto-
mated model building. 1. Tracing protein chains. Acta
Crystallogr., Sect. D: Biol. Crystallogr. 62, 1002–1011.32. Emsley, P., Lohkamp, B., Scott, W. G. & Cowtan, K.
(2010). Features and development of Coot. Acta
Crystallogr., Sect. D: Biol. Crystallogr. 66, 486–501.
33. Adams, P. D., Grosse-Kunstleve, R. W., Hung, L.
W., Ioerger, T. R., McCoy, A. J., Moriarty, N. W.
et al. (2002). PHENIX: building new software for
automated crystallographic structure determination.
Acta Crystallogr., Sect. D: Biol. Crystallogr. 58,
1948–1954.
34. Murshudov, G. N., Skubak, P., Lebedev, A. A., Pannu,
N. S., Steiner, R. A., Nicholls, R. A. et al. (2011).
REFMAC5 for the refinement of macromolecular
crystal structures. Acta Crystallogr., Sect. D: Biol.
Crystallogr. 67, 355–367.
35. Davis, I. W., Leaver-Fay, A., Chen, V. B., Block, J. N.,
Kapral, G. J., Wang, X. et al. (2007). MolProbity: all-
atom contacts and structure validation for
proteins and nucleic acids. Nucleic Acids Res.
35, W375–W383.
36. Krissinel, E. & Henrick, K. (2007). Inference of
macromolecular assemblies from crystalline state.
J. Mol. Biol. 372, 774–797.
37. Hernandez, H. & Robinson, C. V. (2007). Determining
the stoichiometry and interactions of macromolecular
assemblies from mass spectrometry. Nat. Protoc. 2,
715–726.
38. Nettleton, E. J., Sunde, M., Lai, Z., Kelly, J. W.,
Dobson, C. M. & Robinson, C. V. (1998). Protein
subunit interactions and structural integrity of amy-
loidogenic transthyretins: evidence from electrospray
mass spectrometry. J. Mol. Biol. 281, 553–564.
39. Natan, E., Hirschberg, D., Morgner, N., Robinson,
C. V. & Fersht, A. R. (2009). Ultraslow oligomer-
ization equilibria of p53 and its implications. Proc.
Natl Acad. Sci. USA, 106, 14327–14332.
